BLIS Technologies (NZSE:BLT) Scaled Net Operating Assets : 0.25 (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BLIS Technologies's operating assets for the quarter that ended in Sep. 2024 was NZ$4.37 Mil. BLIS Technologies's operating liabilities for the quarter that ended in Sep. 2024 was NZ$1.16 Mil. BLIS Technologies's Total Assets for the quarter that ended in Mar. 2024 was NZ$12.93 Mil. Therefore, BLIS Technologies's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.25.

BLIS Technologies Scaled Net Operating Assets Historical Data

The historical data trend for BLIS Technologies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Scaled Net Operating Assets Chart

BLIS Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.43

0.56

0.55

0.22

0.26

BLIS Technologies Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.16	0.25	0.21	0.27	0.25

Competitive Comparison of BLIS Technologies's Scaled Net Operating Assets

For the Biotechnology subindustry, BLIS Technologies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BLIS Technologies's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's Scaled Net Operating Assets falls into.

BLIS Technologies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BLIS Technologies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(4.336	-	1.056)	/	12.809
=	0.26

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	12.933	-	8.597
=	4.336

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.445	-	0.212	-	0.177
=	1.056

BLIS Technologies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Mar. 2024 )
=	(4.368	-	1.164)	/	12.933
=	0.25

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	13.361	-	8.993
=	4.368

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.648	-	0.343	-	0.141
=	1.164

BLIS Technologies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BLIS Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016

Website

https://www.blis.co.nz

BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).